Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Organ Transplantation Techniques and Outcomes, and Drug-Induced Hepatotoxicity and Protection.
Occult rat hepatitis E virus infection as a cause of cirrhosis and posttransplant recurrence: insights into the role of metagenomics
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients
Reply to: “Shortening the albumin challenge from 48 to 24 hours may lead to overdiagnosis of hepatorenal syndrome-acute kidney injury and overtreatment with terlipressin”
Reply to: “Inclusion of patients with active urinary sediment in treatment of hepatorenal syndrome”
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis.
Fluid resuscitation in patients with cirrhosis and sepsis: A multidisciplinary perspective
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study)
Reply: Aberrant arteries-1 may be better than 2 for the liver, but maybe not the bile duct.
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures.
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
The Use of Rifaximin in Patients With Cirrhosis
Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score
Covid-19 in liver transplant recipients: the French SOT COVID registry
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients